123 related articles for article (PubMed ID: 3493613)
1. [Platelet dysfunction in patients with essential thrombocythemia--acquired von Willebrand's disease].
Mohri H; Asada H; Kodama F; Itoh A; Ohkubo T
Nihon Ketsueki Gakkai Zasshi; 1986 Nov; 49(7):1418-26. PubMed ID: 3493613
[No Abstract] [Full Text] [Related]
2. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease.
Holmberg L; Nilsson IM; Borge L; Gunnarsson M; Sjörin E
N Engl J Med; 1983 Oct; 309(14):816-21. PubMed ID: 6412139
[TBL] [Abstract][Full Text] [Related]
3. [Variant forms of von Willebrand's disease].
Papaian LP; Golovina OG
Ter Arkh; 1990; 62(7):86-92. PubMed ID: 2251672
[TBL] [Abstract][Full Text] [Related]
4. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
5. Effect of desmopressin (DDAVP) on platelet membrane glycoprotein expression in patients with von Willebrand's disease.
Gordz S; Mrowietz C; Pindur G; Park JW; Jung F
Clin Hemorheol Microcirc; 2005; 32(2):83-7. PubMed ID: 15764817
[TBL] [Abstract][Full Text] [Related]
6. Platelet aggregation induced by DDAVP in platelet-type von Willebrand's disease.
Takahashi H; Nagayama R; Hattori A; Shibata A
N Engl J Med; 1984 Mar; 310(11):722-3. PubMed ID: 6608051
[No Abstract] [Full Text] [Related]
7. Acquired von Willebrand's disease in association with essential thrombocythemia: regression following treatment.
Murakawa M; Okamura T; Tsutsumi K; Tanoguchi S; Kamura T; Shibuya T; Harada M; Niho Y
Acta Haematol; 1992; 87(1-2):83-7. PubMed ID: 1585777
[TBL] [Abstract][Full Text] [Related]
8. No influence of blood group on the responsiveness to desmopressin in type I "platelet normal" von Willebrand's disease.
Castaman G; Rodeghiero F
Thromb Haemost; 1995 Mar; 73(3):551-2. PubMed ID: 7667843
[No Abstract] [Full Text] [Related]
9. DDAVP (desmopressin) in the dental management of patients with mild or moderate hemophilia and von Willebrand's disease.
Vierrou AM; de la Fuente B; Poole AE; Hoyer LW
Pediatr Dent; 1985 Dec; 7(4):297-301. PubMed ID: 2938080
[No Abstract] [Full Text] [Related]
10. [Clinical application of new synthetic vasopressin 1-deamino-8-D-arginine vasopressin (DDAVP): hemostatic control of von Willebrand's disease (author's transl)].
Kobayashi I; Takahashi H; Sanada M; Takahashi K; Hattori A; Ito M; Sakuragawa N; Shibata A; Shinada S; Tsukada T
Rinsho Ketsueki; 1979 Apr; 20(4):364-71. PubMed ID: 312954
[No Abstract] [Full Text] [Related]
11. Treatment of von Willebrand's disease.
Mannucci PM
J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
[TBL] [Abstract][Full Text] [Related]
12. [Hemostatic effect of deamino-8-D-arginine vasopressin (DDAVP) in hemophilia A and von Willebrand's disease].
Fukui H; Takase T
Rinsho Ketsueki; 1985 Jul; 26(7):1069-79. PubMed ID: 3932720
[No Abstract] [Full Text] [Related]
13. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
14. [Pathophysiology of platelet anomalies and its analysis. (4). Abnormality of the platelet function in von Willebrand's disease].
Yoshioka A; Takahashi Y
Rinsho Byori; 1983 Nov; 31(11):1176-85. PubMed ID: 6423868
[No Abstract] [Full Text] [Related]
15. Plasma platelet-activating factor (PAF) levels and desmopressin response in children with hemophilia A and von Willebrand's disease.
Kavakli K; Polat A; Hüseyinof A; Nisli G; Aydinok Y
Thromb Haemost; 1999 Apr; 81(4):665-6. PubMed ID: 10235463
[No Abstract] [Full Text] [Related]
16. Effectiveness of D-arginine vasopressin in von Willebrand's disease.
Bala L; Boggio L; Green D
Curr Hematol Rep; 2005 Jan; 4(1):1-2. PubMed ID: 15610653
[No Abstract] [Full Text] [Related]
17. Proliferative diabetic retinopathy in patients with defects of platelet function.
Ho PC; Feman SS; Stein RS; McKee LC
Am J Ophthalmol; 1979 Jul; 88(1):37-9. PubMed ID: 313710
[TBL] [Abstract][Full Text] [Related]
18. Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry.
Giannini S; Mezzasoma AM; Leone M; Gresele P
Haematologica; 2007 Dec; 92(12):1647-54. PubMed ID: 18055988
[TBL] [Abstract][Full Text] [Related]
19. [Platelet aggregation caused by ristocetin--its implication and action mechanism].
Izuchi Y
Nihon Rinsho; 1978 Dec; 36(12):3848-56. PubMed ID: 372624
[No Abstract] [Full Text] [Related]
20. [A trial of adiuretin-SD use in von Willebrand's disease].
Belykh VI; Belykh SI
Ter Arkh; 1990; 62(7):92-4. PubMed ID: 2123575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
